R1	Subsumes Arg1:T1 Arg2:T2	
R2	Has_value Arg1:T1 Arg2:T3	
R3	Subsumes Arg1:T4 Arg2:T5	
R4	Subsumes Arg1:T6 Arg2:T7	
R5	Has_value Arg1:T4 Arg2:T8	
R6	Has_qualifier Arg1:T14 Arg2:T13	
*	OR T12 T14
R7	Has_qualifier Arg1:T15 Arg2:T16	
R8	Subsumes Arg1:T19 Arg2:T21	
R9	Has_value Arg1:T19 Arg2:T20	
*	OR T17 T18
R10	AND Arg1:T17 Arg2:T19	
*	OR T24 T25 T26
R11	Subsumes Arg1:T23 Arg2:T24	
R12	Has_value Arg1:T6 Arg2:T8	
T1	Measurement 0 4	eGFR
T2	Measurement 5 37	Epidermal growth factor receptor
T3	Value 39 49	< 50mL/min
T4	Measurement 51 54	AST
T5	Measurement 55 81	aspartate aminotransferase
T6	Measurement 83 86	ALT
T7	Measurement 87 112	alanine aminotransaminase
T8	Value 114 140	>2.5 upper limit of normal
T10	Pregnancy_considerations 142 169	Pregnant or lactating women
T11	Non-query-able 171 248	Subject who the investigator deems inappropriate to participate in this study
T12	Condition 277 291	bladder cancer
T13	Qualifier 309 315	active
T14	Condition 316 330	bladder cancer
T15	Condition 361 382	macroscopic hematuria
T16	Qualifier 346 360	uninvestigated
T17	Condition 398 413	cardiac failure
T18	Temporal 419 445	history of cardiac failure
T19	Measurement 447 473;481 487	New York Heart Association Stages
T20	Value 488 494	3 to 4
T21	Measurement 475 479	NYHA
T23	Condition 511 527	genetic problems
T24	Condition 536 557	galactose intolerance
T25	Condition 559 582	Lapp lactase deficiency
T26	Condition 586 617	glucose-galactose malabsorption
